0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Opioid Induced Constipation (OIC) Drug Market Insights, Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-5K6641
Home | Market Reports | Health | Pharmacy | Drugs & Medications
Global Opioid Induced Constipation OIC Drug Market Insights Forecast to 2028

Global Opioid Induced Constipation (OIC) Drug Market Insights, Forecast to 2028

Code: QYRE-Auto-5K6641
Report
January 2022
115 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Opioid-induced constipation (OIC) is a common adverse effect experienced by many patients on opioid therapy for chronic pain. OTC medications include stimulant laxatives, stool softeners, and enemas.
Market Analysis and Insights: Global Opioid Induced Constipation (OIC) Drug Market

Due to the COVID-19 pandemic, the global Opioid Induced Constipation (OIC) Drug market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Lubiprostone accounting for % of the Opioid Induced Constipation (OIC) Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
China Opioid Induced Constipation (OIC) Drug market size is valued at US$ million in 2021, while the US and Europe Opioid Induced Constipation (OIC) Drug are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Opioid Induced Constipation (OIC) Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Opioid Induced Constipation (OIC) Drug include Ironwood Pharmaceuticals, Daiichi Sankyo Co, Pfizer, Progenics Pharmaceuticals, Shionogi &, Allergan, Nektar Therapeutics, Purdue Pharma and S.L.A. Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Opioid Induced Constipation (OIC) Drug Scope and Segment
Opioid Induced Constipation (OIC) Drug market is segmented by Type and by Distribution Channel. Players, stakeholders, and other participants in the global Opioid Induced Constipation (OIC) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Distribution Channel for the period 2017-2028.

Segment by Type

Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other
Segment by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

BY COMPANY

Ironwood Pharmaceuticals
Daiichi Sankyo Co
Pfizer
Progenics Pharmaceuticals
Shionogi &
Allergan
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma
Mundipharma International Limited
Ono Pharmaceutical
Takeda Pharmaceutical Company Limited
Theravance Biopharma
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Opioid Induced Constipation (OIC) Drug Product Introduction
1.2 Market by Type
1.2.1 Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Lubiprostone
1.2.3 Methyl Naltrexone Bromide
1.2.4 Naldemedine
1.2.5 Alvimopan
1.2.6 Other
1.3 Market by Distribution Channel
1.3.1 Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Distribution Channel, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Opioid Induced Constipation (OIC) Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Opioid Induced Constipation (OIC) Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Opioid Induced Constipation (OIC) Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Opioid Induced Constipation (OIC) Drug Sales by Region
2.4.1 Global Opioid Induced Constipation (OIC) Drug Sales by Region (2017-2022)
2.4.2 Global Sales Opioid Induced Constipation (OIC) Drug by Region (2023-2028)
2.5 Global Opioid Induced Constipation (OIC) Drug Revenue by Region
2.5.1 Global Opioid Induced Constipation (OIC) Drug Revenue by Region (2017-2022)
2.5.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Opioid Induced Constipation (OIC) Drug Sales by Manufacturers
3.1.1 Global Top Opioid Induced Constipation (OIC) Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Opioid Induced Constipation (OIC) Drug in 2021
3.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers
3.2.1 Global Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Opioid Induced Constipation (OIC) Drug Revenue in 2021
3.3 Global Opioid Induced Constipation (OIC) Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Opioid Induced Constipation (OIC) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Opioid Induced Constipation (OIC) Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Opioid Induced Constipation (OIC) Drug Sales by Type
4.1.1 Global Opioid Induced Constipation (OIC) Drug Historical Sales by Type (2017-2022)
4.1.2 Global Opioid Induced Constipation (OIC) Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2017-2028)
4.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Type
4.2.1 Global Opioid Induced Constipation (OIC) Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Opioid Induced Constipation (OIC) Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2017-2028)
4.3 Global Opioid Induced Constipation (OIC) Drug Price by Type
4.3.1 Global Opioid Induced Constipation (OIC) Drug Price by Type (2017-2022)
4.3.2 Global Opioid Induced Constipation (OIC) Drug Price Forecast by Type (2023-2028)
5 Market Size by Distribution Channel
5.1 Global Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel
5.1.1 Global Opioid Induced Constipation (OIC) Drug Historical Sales by Distribution Channel (2017-2022)
5.1.2 Global Opioid Induced Constipation (OIC) Drug Forecasted Sales by Distribution Channel (2023-2028)
5.1.3 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2028)
5.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel
5.2.1 Global Opioid Induced Constipation (OIC) Drug Historical Revenue by Distribution Channel (2017-2022)
5.2.2 Global Opioid Induced Constipation (OIC) Drug Forecasted Revenue by Distribution Channel (2023-2028)
5.2.3 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel (2017-2028)
5.3 Global Opioid Induced Constipation (OIC) Drug Price by Distribution Channel
5.3.1 Global Opioid Induced Constipation (OIC) Drug Price by Distribution Channel (2017-2022)
5.3.2 Global Opioid Induced Constipation (OIC) Drug Price Forecast by Distribution Channel (2023-2028)
6 North America
6.1 North America Opioid Induced Constipation (OIC) Drug Market Size by Type
6.1.1 North America Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2028)
6.1.2 North America Opioid Induced Constipation (OIC) Drug Revenue by Type (2017-2028)
6.2 North America Opioid Induced Constipation (OIC) Drug Market Size by Distribution Channel
6.2.1 North America Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2028)
6.2.2 North America Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2017-2028)
6.3 North America Opioid Induced Constipation (OIC) Drug Market Size by Country
6.3.1 North America Opioid Induced Constipation (OIC) Drug Sales by Country (2017-2028)
6.3.2 North America Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Opioid Induced Constipation (OIC) Drug Market Size by Type
7.1.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2028)
7.1.2 Europe Opioid Induced Constipation (OIC) Drug Revenue by Type (2017-2028)
7.2 Europe Opioid Induced Constipation (OIC) Drug Market Size by Distribution Channel
7.2.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2028)
7.2.2 Europe Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2017-2028)
7.3 Europe Opioid Induced Constipation (OIC) Drug Market Size by Country
7.3.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2017-2028)
7.3.2 Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Size by Type
8.1.1 Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Size by Distribution Channel
8.2.1 Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2028)
8.2.2 Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2017-2028)
8.3 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Size by Region
8.3.1 Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Opioid Induced Constipation (OIC) Drug Market Size by Type
9.1.1 Latin America Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2028)
9.1.2 Latin America Opioid Induced Constipation (OIC) Drug Revenue by Type (2017-2028)
9.2 Latin America Opioid Induced Constipation (OIC) Drug Market Size by Distribution Channel
9.2.1 Latin America Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2028)
9.2.2 Latin America Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2017-2028)
9.3 Latin America Opioid Induced Constipation (OIC) Drug Market Size by Country
9.3.1 Latin America Opioid Induced Constipation (OIC) Drug Sales by Country (2017-2028)
9.3.2 Latin America Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Size by Type
10.1.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Size by Distribution Channel
10.2.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2028)
10.2.2 Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2017-2028)
10.3 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Size by Country
10.3.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Ironwood Pharmaceuticals
11.1.1 Ironwood Pharmaceuticals Corporation Information
11.1.2 Ironwood Pharmaceuticals Overview
11.1.3 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Ironwood Pharmaceuticals Recent Developments
11.2 Daiichi Sankyo Co
11.2.1 Daiichi Sankyo Co Corporation Information
11.2.2 Daiichi Sankyo Co Overview
11.2.3 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Daiichi Sankyo Co Recent Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Pfizer Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Recent Developments
11.4 Progenics Pharmaceuticals
11.4.1 Progenics Pharmaceuticals Corporation Information
11.4.2 Progenics Pharmaceuticals Overview
11.4.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Progenics Pharmaceuticals Recent Developments
11.5 Shionogi &
11.5.1 Shionogi & Corporation Information
11.5.2 Shionogi & Overview
11.5.3 Shionogi & Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Shionogi & Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Shionogi & Recent Developments
11.6 Allergan
11.6.1 Allergan Corporation Information
11.6.2 Allergan Overview
11.6.3 Allergan Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Allergan Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Allergan Recent Developments
11.7 Nektar Therapeutics
11.7.1 Nektar Therapeutics Corporation Information
11.7.2 Nektar Therapeutics Overview
11.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Nektar Therapeutics Recent Developments
11.8 Purdue Pharma
11.8.1 Purdue Pharma Corporation Information
11.8.2 Purdue Pharma Overview
11.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Purdue Pharma Recent Developments
11.9 S.L.A. Pharma
11.9.1 S.L.A. Pharma Corporation Information
11.9.2 S.L.A. Pharma Overview
11.9.3 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 S.L.A. Pharma Recent Developments
11.10 Mundipharma International Limited
11.10.1 Mundipharma International Limited Corporation Information
11.10.2 Mundipharma International Limited Overview
11.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Mundipharma International Limited Recent Developments
11.11 Ono Pharmaceutical
11.11.1 Ono Pharmaceutical Corporation Information
11.11.2 Ono Pharmaceutical Overview
11.11.3 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Ono Pharmaceutical Recent Developments
11.12 Takeda Pharmaceutical Company Limited
11.12.1 Takeda Pharmaceutical Company Limited Corporation Information
11.12.2 Takeda Pharmaceutical Company Limited Overview
11.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Takeda Pharmaceutical Company Limited Recent Developments
11.13 Theravance Biopharma
11.13.1 Theravance Biopharma Corporation Information
11.13.2 Theravance Biopharma Overview
11.13.3 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Theravance Biopharma Recent Developments
11.14 Bausch Health
11.14.1 Bausch Health Corporation Information
11.14.2 Bausch Health Overview
11.14.3 Bausch Health Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Bausch Health Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Bausch Health Recent Developments
11.15 Cosmo Pharmaceuticals SA
11.15.1 Cosmo Pharmaceuticals SA Corporation Information
11.15.2 Cosmo Pharmaceuticals SA Overview
11.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Cosmo Pharmaceuticals SA Recent Developments
11.16 Daewoong Pharmaceutical
11.16.1 Daewoong Pharmaceutical Corporation Information
11.16.2 Daewoong Pharmaceutical Overview
11.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Daewoong Pharmaceutical Recent Developments
11.17 C.B. Fleet Company
11.17.1 C.B. Fleet Company Corporation Information
11.17.2 C.B. Fleet Company Overview
11.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 C.B. Fleet Company Recent Developments
11.18 Sucampo Pharmaceuticals
11.18.1 Sucampo Pharmaceuticals Corporation Information
11.18.2 Sucampo Pharmaceuticals Overview
11.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Sucampo Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Opioid Induced Constipation (OIC) Drug Industry Chain Analysis
12.2 Opioid Induced Constipation (OIC) Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Opioid Induced Constipation (OIC) Drug Production Mode & Process
12.4 Opioid Induced Constipation (OIC) Drug Sales and Marketing
12.4.1 Opioid Induced Constipation (OIC) Drug Sales Channels
12.4.2 Opioid Induced Constipation (OIC) Drug Distributors
12.5 Opioid Induced Constipation (OIC) Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Opioid Induced Constipation (OIC) Drug Industry Trends
13.2 Opioid Induced Constipation (OIC) Drug Market Drivers
13.3 Opioid Induced Constipation (OIC) Drug Market Challenges
13.4 Opioid Induced Constipation (OIC) Drug Market Restraints
14 Key Findings in The Global Opioid Induced Constipation (OIC) Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Lubiprostone
    Table 3. Major Manufacturers of Methyl Naltrexone Bromide
    Table 4. Major Manufacturers of Naldemedine
    Table 5. Major Manufacturers of Alvimopan
    Table 6. Major Manufacturers of Other
    Table 7. Global Opioid Induced Constipation (OIC) Drug Market Size Growth Rate by Distribution Channel, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Opioid Induced Constipation (OIC) Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Opioid Induced Constipation (OIC) Drug Sales by Region (2017-2022) & (K Units)
    Table 10. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2017-2022)
    Table 11. Global Opioid Induced Constipation (OIC) Drug Sales by Region (2023-2028) & (K Units)
    Table 12. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2023-2028)
    Table 13. Global Opioid Induced Constipation (OIC) Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2017-2022)
    Table 15. Global Opioid Induced Constipation (OIC) Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2023-2028)
    Table 17. Global Opioid Induced Constipation (OIC) Drug Sales by Manufacturers (2017-2022) & (K Units)
    Table 18. Global Opioid Induced Constipation (OIC) Drug Sales Share by Manufacturers (2017-2022)
    Table 19. Global Opioid Induced Constipation (OIC) Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers (2017-2022)
    Table 21. Opioid Induced Constipation (OIC) Drug Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 22. Global Opioid Induced Constipation (OIC) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Opioid Induced Constipation (OIC) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Induced Constipation (OIC) Drug as of 2021)
    Table 24. Opioid Induced Constipation (OIC) Drug Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Opioid Induced Constipation (OIC) Drug Product Offered
    Table 26. Date of Manufacturers Enter into Opioid Induced Constipation (OIC) Drug Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2022) & (K Units)
    Table 29. Global Opioid Induced Constipation (OIC) Drug Sales by Type (2023-2028) & (K Units)
    Table 30. Global Opioid Induced Constipation (OIC) Drug Sales Share by Type (2017-2022)
    Table 31. Global Opioid Induced Constipation (OIC) Drug Sales Share by Type (2023-2028)
    Table 32. Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Opioid Induced Constipation (OIC) Drug Revenue Share by Type (2017-2022)
    Table 35. Global Opioid Induced Constipation (OIC) Drug Revenue Share by Type (2023-2028)
    Table 36. Opioid Induced Constipation (OIC) Drug Price by Type (2017-2022) & (USD/Unit)
    Table 37. Global Opioid Induced Constipation (OIC) Drug Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 38. Global Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2022) & (K Units)
    Table 39. Global Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2023-2028) & (K Units)
    Table 40. Global Opioid Induced Constipation (OIC) Drug Sales Share by Distribution Channel (2017-2022)
    Table 41. Global Opioid Induced Constipation (OIC) Drug Sales Share by Distribution Channel (2023-2028)
    Table 42. Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 43. Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 44. Global Opioid Induced Constipation (OIC) Drug Revenue Share by Distribution Channel (2017-2022)
    Table 45. Global Opioid Induced Constipation (OIC) Drug Revenue Share by Distribution Channel (2023-2028)
    Table 46. Opioid Induced Constipation (OIC) Drug Price by Distribution Channel (2017-2022) & (USD/Unit)
    Table 47. Global Opioid Induced Constipation (OIC) Drug Price Forecast by Distribution Channel (2023-2028) & (USD/Unit)
    Table 48. North America Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2022) & (K Units)
    Table 49. North America Opioid Induced Constipation (OIC) Drug Sales by Type (2023-2028) & (K Units)
    Table 50. North America Opioid Induced Constipation (OIC) Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Opioid Induced Constipation (OIC) Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2022) & (K Units)
    Table 53. North America Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2023-2028) & (K Units)
    Table 54. North America Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 55. North America Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 56. North America Opioid Induced Constipation (OIC) Drug Sales by Country (2017-2022) & (K Units)
    Table 57. North America Opioid Induced Constipation (OIC) Drug Sales by Country (2023-2028) & (K Units)
    Table 58. North America Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Opioid Induced Constipation (OIC) Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2022) & (K Units)
    Table 61. Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2023-2028) & (K Units)
    Table 62. Europe Opioid Induced Constipation (OIC) Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Opioid Induced Constipation (OIC) Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2022) & (K Units)
    Table 65. Europe Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2023-2028) & (K Units)
    Table 66. Europe Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 67. Europe Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 68. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2017-2022) & (K Units)
    Table 69. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2023-2028) & (K Units)
    Table 70. Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2022) & (K Units)
    Table 73. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Type (2023-2028) & (K Units)
    Table 74. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2022) & (K Units)
    Table 77. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2023-2028) & (K Units)
    Table 78. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Region (2017-2022) & (K Units)
    Table 81. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Region (2023-2028) & (K Units)
    Table 82. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2022) & (K Units)
    Table 85. Latin America Opioid Induced Constipation (OIC) Drug Sales by Type (2023-2028) & (K Units)
    Table 86. Latin America Opioid Induced Constipation (OIC) Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Opioid Induced Constipation (OIC) Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2022) & (K Units)
    Table 89. Latin America Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2023-2028) & (K Units)
    Table 90. Latin America Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 91. Latin America Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 92. Latin America Opioid Induced Constipation (OIC) Drug Sales by Country (2017-2022) & (K Units)
    Table 93. Latin America Opioid Induced Constipation (OIC) Drug Sales by Country (2023-2028) & (K Units)
    Table 94. Latin America Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Opioid Induced Constipation (OIC) Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2022) & (K Units)
    Table 97. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2023-2028) & (K Units)
    Table 98. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2022) & (K Units)
    Table 101. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2023-2028) & (K Units)
    Table 102. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2017-2022) & (K Units)
    Table 105. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2023-2028) & (K Units)
    Table 106. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Ironwood Pharmaceuticals Corporation Information
    Table 109. Ironwood Pharmaceuticals Description and Major Businesses
    Table 110. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 111. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Ironwood Pharmaceuticals Recent Developments
    Table 113. Daiichi Sankyo Co Corporation Information
    Table 114. Daiichi Sankyo Co Description and Major Businesses
    Table 115. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 116. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Daiichi Sankyo Co Recent Developments
    Table 118. Pfizer Corporation Information
    Table 119. Pfizer Description and Major Businesses
    Table 120. Pfizer Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 121. Pfizer Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Pfizer Recent Developments
    Table 123. Progenics Pharmaceuticals Corporation Information
    Table 124. Progenics Pharmaceuticals Description and Major Businesses
    Table 125. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 126. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Progenics Pharmaceuticals Recent Developments
    Table 128. Shionogi & Corporation Information
    Table 129. Shionogi & Description and Major Businesses
    Table 130. Shionogi & Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 131. Shionogi & Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Shionogi & Recent Developments
    Table 133. Allergan Corporation Information
    Table 134. Allergan Description and Major Businesses
    Table 135. Allergan Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 136. Allergan Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Allergan Recent Developments
    Table 138. Nektar Therapeutics Corporation Information
    Table 139. Nektar Therapeutics Description and Major Businesses
    Table 140. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 141. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Nektar Therapeutics Recent Developments
    Table 143. Purdue Pharma Corporation Information
    Table 144. Purdue Pharma Description and Major Businesses
    Table 145. Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 146. Purdue Pharma Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Purdue Pharma Recent Developments
    Table 148. S.L.A. Pharma Corporation Information
    Table 149. S.L.A. Pharma Description and Major Businesses
    Table 150. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 151. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. S.L.A. Pharma Recent Developments
    Table 153. Mundipharma International Limited Corporation Information
    Table 154. Mundipharma International Limited Description and Major Businesses
    Table 155. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 156. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Mundipharma International Limited Recent Developments
    Table 158. Ono Pharmaceutical Corporation Information
    Table 159. Ono Pharmaceutical Description and Major Businesses
    Table 160. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 161. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. Ono Pharmaceutical Recent Developments
    Table 163. Takeda Pharmaceutical Company Limited Corporation Information
    Table 164. Takeda Pharmaceutical Company Limited Description and Major Businesses
    Table 165. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 166. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. Takeda Pharmaceutical Company Limited Recent Developments
    Table 168. Theravance Biopharma Corporation Information
    Table 169. Theravance Biopharma Description and Major Businesses
    Table 170. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 171. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 172. Theravance Biopharma Recent Developments
    Table 173. Bausch Health Corporation Information
    Table 174. Bausch Health Description and Major Businesses
    Table 175. Bausch Health Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 176. Bausch Health Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 177. Bausch Health Recent Developments
    Table 178. Cosmo Pharmaceuticals SA Corporation Information
    Table 179. Cosmo Pharmaceuticals SA Description and Major Businesses
    Table 180. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 181. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 182. Cosmo Pharmaceuticals SA Recent Developments
    Table 183. Daewoong Pharmaceutical Corporation Information
    Table 184. Daewoong Pharmaceutical Description and Major Businesses
    Table 185. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 186. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 187. Daewoong Pharmaceutical Recent Developments
    Table 188. C.B. Fleet Company Corporation Information
    Table 189. C.B. Fleet Company Description and Major Businesses
    Table 190. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 191. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 192. C.B. Fleet Company Recent Developments
    Table 193. Sucampo Pharmaceuticals Corporation Information
    Table 194. Sucampo Pharmaceuticals Description and Major Businesses
    Table 195. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 196. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 197. Sucampo Pharmaceuticals Recent Developments
    Table 198. Key Raw Materials Lists
    Table 199. Raw Materials Key Suppliers Lists
    Table 200. Opioid Induced Constipation (OIC) Drug Distributors List
    Table 201. Opioid Induced Constipation (OIC) Drug Customers List
    Table 202. Opioid Induced Constipation (OIC) Drug Market Trends
    Table 203. Opioid Induced Constipation (OIC) Drug Market Drivers
    Table 204. Opioid Induced Constipation (OIC) Drug Market Challenges
    Table 205. Opioid Induced Constipation (OIC) Drug Market Restraints
    Table 206. Research Programs/Design for This Report
    Table 207. Key Data Information from Secondary Sources
    Table 208. Key Data Information from Primary Sources
List of Figures
    Figure 1. Opioid Induced Constipation (OIC) Drug Product Picture
    Figure 3. Global Opioid Induced Constipation (OIC) Drug Market Share by Type in 2021 & 2028
    Figure 3. Lubiprostone Product Picture
    Figure 4. Methyl Naltrexone Bromide Product Picture
    Figure 5. Naldemedine Product Picture
    Figure 6. Alvimopan Product Picture
    Figure 7. Other Product Picture
    Figure 8. Global Opioid Induced Constipation (OIC) Drug Market Share by Distribution Channel in 2021 & 2028
    Figure 9. Hospital Pharmacies
    Figure 10. Retail Pharmacies
    Figure 11. Online Pharmacies
    Figure 12. Opioid Induced Constipation (OIC) Drug Report Years Considered
    Figure 13. Global Opioid Induced Constipation (OIC) Drug Sales 2017-2028 (K Units)
    Figure 14. Global Opioid Induced Constipation (OIC) Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Opioid Induced Constipation (OIC) Drug Revenue 2017-2028 (US$ Million)
    Figure 16. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2017-2022)
    Figure 18. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2023-2028)
    Figure 19. North America Opioid Induced Constipation (OIC) Drug Sales YoY (2017-2028) & (K Units)
    Figure 20. North America Opioid Induced Constipation (OIC) Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Opioid Induced Constipation (OIC) Drug Sales YoY (2017-2028) & (K Units)
    Figure 22. Europe Opioid Induced Constipation (OIC) Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales YoY (2017-2028) & (K Units)
    Figure 24. Asia-Pacific Opioid Induced Constipation (OIC) Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Opioid Induced Constipation (OIC) Drug Sales YoY (2017-2028) & (K Units)
    Figure 26. Latin America Opioid Induced Constipation (OIC) Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales YoY (2017-2028) & (K Units)
    Figure 28. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Opioid Induced Constipation (OIC) Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Opioid Induced Constipation (OIC) Drug in the World: Market Share by Opioid Induced Constipation (OIC) Drug Revenue in 2021
    Figure 31. Global Opioid Induced Constipation (OIC) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2017-2028)
    Figure 33. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2017-2028)
    Figure 34. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2028)
    Figure 35. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel (2017-2028)
    Figure 36. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2017-2028)
    Figure 37. North America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2017-2028)
    Figure 38. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2028)
    Figure 39. North America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel (2017-2028)
    Figure 40. North America Opioid Induced Constipation (OIC) Drug Sales Share by Country (2017-2028)
    Figure 41. North America Opioid Induced Constipation (OIC) Drug Revenue Share by Country (2017-2028)
    Figure 42. U.S. Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2017-2028)
    Figure 45. Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2028)
    Figure 47. Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel (2017-2028)
    Figure 48. Europe Opioid Induced Constipation (OIC) Drug Sales Share by Country (2017-2028)
    Figure 49. Europe Opioid Induced Constipation (OIC) Drug Revenue Share by Country (2017-2028)
    Figure 50. Germany Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (US$ Million)
    Figure 51. France Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2028)
    Figure 58. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel (2017-2028)
    Figure 59. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Share by Region (2017-2028)
    Figure 61. China Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (US$ Million)
    Figure 64. India Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2028)
    Figure 74. Latin America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel (2017-2028)
    Figure 75. Latin America Opioid Induced Constipation (OIC) Drug Sales Share by Country (2017-2028)
    Figure 76. Latin America Opioid Induced Constipation (OIC) Drug Revenue Share by Country (2017-2028)
    Figure 77. Mexico Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2028)
    Figure 83. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel (2017-2028)
    Figure 84. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Share by Country (2017-2028)
    Figure 86. Turkey Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (US$ Million)
    Figure 88. U.A.E Opioid Induced Constipation (OIC) Drug Revenue (2017-2028) & (US$ Million)
    Figure 89. Opioid Induced Constipation (OIC) Drug Value Chain
    Figure 90. Opioid Induced Constipation (OIC) Drug Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners

RELATED REPORTS

Global Nebivolol Hydrochloride Market Insights Forecast to 2028
Global Nebivolol Hydrochloride Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-12T7632
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Nefopam Hydrochloride Market Insights Forecast to 2028
Global Nefopam Hydrochloride Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-36U7490
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Naratriptan Hydrochloride Market Insights Forecast to 2028
Global Naratriptan Hydrochloride Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-14C7602
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Nelfinavir Market Insights Forecast to 2028
Global Nelfinavir Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-25I7469
Fri May 13 00:00:00 UTC 2022

Add to Cart